Join the Whole Body Health Pilot Program
Launching 8 March – Open for sign-up NOW!
14-Day Money-Back Guarantee
Early Bird Price: $795.00
This section reflects other conditions that appear to have a metabolic component. The conditions listed in the contents are emergent in terms of the evidence – they may have features of metabolic dysregulation that respond to therapeutic carbohydrate restriction.
This section should be considered as emergent in terms of the evidence and the role of diet as supportive.
Duraj, T. et al. (2024a) ‘Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma’, BMC Medicine, 22(1), p. 578. Available at: https://doi.org/10.1186/s12916-024-03775-4.
Lane J, Brown NI, Williams S, Plaisance EP, Fontaine KR. Ketogenic Diet for Cancer: Critical Assessment and Research Recommendations. Nutrients. 2021;13(10):3562. doi:10.3390/nu13103562
Kleckner, A.S. et al. (2024) ‘Time-restricted eating to address persistent cancer-related fatigue among cancer survivors: A randomized controlled trial’, Research Square, p. rs.3.rs-5530166. Available at: https://doi.org/10.21203/rs.3.rs-5530166/v1. (Preprint)
Liang, Z. et al. (2025) ‘Comprehensive Overview of Ketone Bodies in Cancer Metabolism: Mechanisms and Application’, Biomedicines, 13(1), p. 210. Available at: https://doi.org/10.3390/biomedicines13010210.
Rajakumar, G. et al. (2024) ‘Effect of ketogenic diets on insulin-like growth factor (IGF)-1 in humans: A systematic review and meta-analysis’, Ageing Research Reviews, p. 102531. Available at: https://doi.org/10.1016/j.arr.2024.102531.
Anil, A. et al. (2024) ‘Uncovering the Links Between Dietary Sugar and Cancer: A Narrative Review Exploring the Impact of Dietary Sugar and Fasting on Cancer Risk and Prevention’, Cureus [Preprint]. Available at: https://doi.org/10.7759/cureus.67434.
Duraj, T. et al. (2024a) ‘Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma’, BMC Medicine, 22(1), p. 578. Available at: https://doi.org/10.1186/s12916-024-03775-4.
Valerio, J. et al. (2024) ‘Systematic Review and Clinical Insights: The Role of the Ketogenic Diet in Managing Glioblastoma in Cancer Neuroscience’, Journal of Personalized Medicine, 14(9), p. 929. Available at: https://doi.org/10.3390/jpm14090929.
Case Reports
Bahrami, A. et al. (2024) ‘Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study’, Frontiers in Nutrition, 11, p. 1483707. Available at: https://doi.org/10.3389/fnut.2024.1483707.
Javed, S.R. et al. (2024) ‘Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer’, British Journal of Cancer [Preprint]. Available at: https://doi.org/10.1038/s41416-024-02833-1.
Castaldo, G. et al. (2024) ‘The Effectiveness of the Low-Glycemic and Insulinemic (LOGI) Regimen in Maintaining the Benefits of the VLCKD in Fibromyalgia Patients’, Nutrients, 16(23), p. 4161. Available at: https://doi.org/10.3390/nu16234161.
Ciaffi, J. et al. (2023) ‘Efficacy, safety and tolerability of very low-calorie ketogenic diet in obese women with fibromyalgia: a pilot interventional study’, Frontiers in Nutrition, 10. Available at: https://www.frontiersin.org/articles/10.3389/fnut.2023.1219321.
Kim, E.R. et al. (2022) ‘Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21’, Frontiers in Immunology, 13, p. 843520. doi:10.3389/fimmu.2022.843520.
Ruth MR, Port AM, Shah M, et al. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metab Clin Exp. 2013;62(12):1779-1787. doi:10.1016/j.metabol.2013.07.006 PDF
Cipryan L, Dostal T, Plews DJ, Hofmann P, Laursen PB. Adiponectin-leptin ratio increases after a 12-week very low-carbohydrate, high-fat diet and exercise training in healthy individuals: A non-randomized, parallel-group study. Nutrition Research. Published online December 10, 2020. doi:10.1016/j.nutres.2020.12.012
Barrea, L. et al. (2022) ‘Phase angle as an easy diagnostic tool for the nutritionist in the evaluation of inflammatory changes during the active stage of a very low-calorie ketogenic diet’, International Journal of Obesity (2005) [Preprint]. doi:10.1038/s41366-022-01152-w.
Emamdoost, S. (2024) ‘Can the ketogenic diet improve the hamstring muscle rupture? A narrative review’. Available at: https://www.jsportrs.com/article_201640_a8fcfb3c02003d10a6e4829319b41789.pdf
Rashid T, Wilson C, Ebringer A. The Link between Ankylosing Spondylitis, Crohn’s Disease, Klebsiella, and Starch Consumption. Journal of Immunology Research. doi:10.1155/2013/872632
Phillips MCL, Murtagh DKJ, Ziad F, Johnston SE, Moon BG. Impact of a Ketogenic Diet on Sporadic Inclusion Body Myositis: A Case Study. Front Neurol. 2020;11. doi:10.3389/fneur.2020.582402
Cull, M. (2024) ‘Weight loss for obese patients as a treatment of hip and knee osteoarthritis: A scoping review’, Journal of Metabolic Health, 7(1), p. 8. Available at: https://doi.org/10.4102/jmh.v7i1.97.
Wiggins, A.M. et al. (2024) ‘The effect of a low-carbohydrate diet on evoked pain and quality of life in Non-Hispanic black women with knee osteoarthritis: a pilot study’, BMC Musculoskeletal Disorders, 25, p. 1043. Available at: https://doi.org/10.1186/s12891-024-08170-x.
Karačić, A. et al. (2024) ‘The gut microbiome without any plant food? A case study on the gut microbiome of a healthy carnivore’, Microbiota and Host, 1(aop). Available at: https://doi.org/10.1530/MAH-24-0006.
Norwitz, N.G. and Soto-Mota, A. (2024) ‘Case report: Carnivore–ketogenic diet for the treatment of inflammatory bowel disease: a case series of 10 patients’, Frontiers in Nutrition, 11. Available at: https://doi.org/10.3389/fnut.2024.1467475.
Keferstein, L.G. (2024) ‘Carnivore Diet as Regenerative Immunotherapy for Inflammatory Bowel Disease: Literature Review, A Novel Hypothesis and Experimental Design’. Preprints. Available at: https://doi.org/10.20944/preprints202409.0108.v1.
This section is intended to reflect the general lack of consensus (especially with regard to fibre) regarding best management of various gastrointestinal disorders and supports individual tailoring through elimination protocols. Common themes include whole foods, reduced carbohydrate, FODMAP and low/no/high fibre.
O’Hearn, L.A. (2024) ‘Signals of energy availability in sleep: consequences of a fat-based metabolism’, Frontiers in Nutrition, 11, p. 1397185. Available at: https://doi.org/10.3389/fnut.2024.1397185.
Bhartiya, S. (2024) ‘The Metabolic Shift: Unraveling the Potential of the Ketogenic Diet in Glaucoma Management’, Journal of Current Glaucoma Practice, 18(2), p. 43. Available at: https://doi.org/10.5005/jp-journals-10078-1435.
There are a number of conditions that may be classified as having an autoimmune component. Many of these can be found in other sections e.g for Rheumatoid Arthritis see Pain/Inflammation – Arthritis, for Crohn’s disease see Gastrointestinal etc. The studies below don’t fit neatly into other categories or are too small for their own section.
There are a number of conditions that may be classified as having an endocrine component. Many of these can be found in other sections. The studies below don’t fit neatly into other categories or are too small for their own section.
For more articles on bone health as pertains to menopause, see the section under reproductive health and menopause.
O’Hearn, L.A. (2024) ‘Signals of energy availability in sleep: consequences of a fat-based metabolism’, Frontiers in Nutrition, 11, p. 1397185. Available at: https://doi.org/10.3389/fnut.2024.1397185.
Launching 8 March – Open for sign-up NOW!
14-Day Money-Back Guarantee